Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First, is scheduled to end on July 31st. Learn about your options to continue receiving care at Temple Health.

Fox Chase Cancer Center News

New GIST Studies Look to Overcome TKI Resistance

Fox Chase Researchers Continue Commitment to Rare GIST Tumors

Several enrolling clinical trials are exploring avenues to overcoming TKI resistance.

The management of gastrointestinal stromal tumors (GIST) was revolutionized with the introduction of tyrosine kinase

VIEW STORY